In the golden autumn of 2024, September, Zhongjiu Flash Medical Technology Co., Ltd. welcomed the significant moment of its second anniversary. Since its establishment in 2022 with the "Mianyang speed" of "69 days" registration, the company has been committed to driving scientific and technological innovation, dedicated to providing safer and more effective next-generation tumor treatment solutions through continuous innovation and technological breakthroughs. We firmly believe that improving the survival rate and quality of life of cancer patients and contributing to human health is our relentless pursuit.

Flash radiotherapy technology, as the third technological revolution in the global field of tumor radiotherapy, can irradiate tumors with an ultra-high dose rate (≥40Gy/s) in an extremely short time. It can rapidly destroy tumor cells while minimizing damage to surrounding normal tissues, thus achieving the goal of efficient and precise tumor treatment and showing a broad clinical application prospect.

After the establishment of Zhongjiu Flash, the project team has transformed and absorbed the technical foundation of the China Academy of Engineering Physics, laying a solid technical foundation for the company. Starting from this point, Zhongjiu Flash has carried out the miniaturization and engineering research and development of electron beam Flash radiotherapy equipment and X-ray Flash radiotherapy equipment, promoting the transformation of the two products from concept to engineering application.

On the occasion of the second anniversary, the company has successfully overcome the technology of miniaturized ultra-high dose rate radiation sources, solving the monitoring difficulties of Flash ultra-high dose rate that have plagued the entire industry. It has successfully completed the development of the engineering prototype of the electron beam Flash clinical prototype and the principle prototype of the X-ray Flash radiotherapy equipment, with a dose rate exceeding the global record by more than four times. This breakthrough has supported dozens of institutions to carry out tens of thousands of experiments, promoting China's research in the field of Flash radiotherapy to the forefront of the world.

The R&D team's achievements were honored as one of the "Top Ten Scientific Progresses in Sichuan" in 2023. The company has always adhered to the concept of steady development, promoting product application and technological progress with a pragmatic attitude, striving to provide a safer, more effective, and more efficient new radiotherapy treatment plan for a wide range of cancer patients.

Zhongjiu Flash highly values the introduction and cultivation of talent, actively building a professional team with international vision and innovation capabilities, led by Academician Fan Guobin as the chief scientist. With the strong support of provincial and municipal governments, the company has built high-end technology innovation platforms and industrialization innovation platforms, focusing on industry resources to promote the dual development of technology research and development and industrial transformation. With the joint efforts of all employees, the company has made significant progress in scientific and technological innovation and product research and development, showing a good momentum of sustainable development.

On the occasion of the second anniversary, the company has carefully prepared commemorative gifts symbolizing cooperation, sharing, and harvest for all employees, expressing gratitude for their hard work and implying the joy of sharing the results with the company. The company highly recognizes the important contribution of every employee in the growth of the company and hopes that the gifts symbolizing harvest and unity can motivate everyone to continue to work hard and jointly promote the further development of the company. The company will continue to focus on employees and jointly face future challenges and opportunities.

Looking forward, Zhongjiu Flash will continue to focus on the research and development and promotion of FLASH radiotherapy technology, actively promoting its application in tumor treatment and other fields. The company will further increase investment in scientific research, strengthen international cooperation, and continuously improve technical levels and product quality, contributing to the development of global medical technology and becoming a leading global provider of high-end medical equipment and services.